Clinical Trial Update: Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing indomethacin to placebo in women with preterm premature rupture of membranes. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Preterm Premature Rupture of Membranes | Phase 2 | Status: UNKNOWN